Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-24-011973
Filing Date
2024-03-29
Accepted
2024-03-29 16:05:43
Documents
54
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1479153
2 ex10-6.htm EX-10.6 303550
3 ex23-1.htm EX-23.1 3707
4 ex31-1.htm EX-31.1 15763
5 ex31-2.htm EX-31.2 15411
6 ex32-1.htm EX-32.1 6341
7 ex32-2.htm EX-32.2 6809
8 ex10-6_001.jpg GRAPHIC 57019
9 ex10-6_004.jpg GRAPHIC 2064
10 ex10-6_005.jpg GRAPHIC 2964
  Complete submission text file 0001493152-24-011973.txt   4747522

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE inti-20231231.xsd EX-101.SCH 22358
12 XBRL CALCULATION FILE inti-20231231_cal.xml EX-101.CAL 39947
13 XBRL DEFINITION FILE inti-20231231_def.xml EX-101.DEF 104835
14 XBRL LABEL FILE inti-20231231_lab.xml EX-101.LAB 222593
15 XBRL PRESENTATION FILE inti-20231231_pre.xml EX-101.PRE 176289
58 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 430483
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Filer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13467 | Film No.: 24804152
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)